| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.00073 | 1 |